天賜材料(002709.SZ):終止公開發行可轉債事項
格隆匯3月13日丨天賜材料(002709.SZ)公佈,2020年3月12日,公司第四屆董事會第四十八次會議、第四屆監事會第三十九次會議審議通過了《關於終止公開發行可轉換公司債券事項的議案》。
之前公告披露,擬發行可轉債募集資金總額不超過人民幣11.4億元(含)。
鑑於市場環境發生變化,同時綜合公司業績預期,以及公司項目總體統籌安排,公司決定終止上述可轉債發行事宜。對於此次投資項目年產40萬噸硫磺制酸項目及年產20萬噸高鈷氫氧化鎳項目(一期A段),公司將繼續以自有資金及其他資金籌措方式籌措資金進行建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.